## Baseline Assessment in RCT Design **Key Point:** Baseline investigations in an RCT serve to document the comparability of randomized groups and establish the starting point for outcome measurement. They are NOT interventions but rather descriptive assessments. ### Purpose of Baseline Investigations Baseline data collection in RCTs achieves two critical objectives: 1. **Verification of group comparability** — ensures randomization was effective 2. **Adjustment for confounders** — allows stratified analysis if imbalances occur ### What Should Be Documented at Baseline | Element | Rationale | |---------|----------| | Demographic variables (age, sex, occupation) | Establish population characteristics | | Clinical baseline measurements (BP, weight, comorbidities) | Quantify starting disease severity | | Relevant biomarkers (creatinine, lipids if applicable) | Document organ function status | | Inclusion/exclusion criteria verification | Confirm eligibility | | Randomization method documentation | Prove allocation concealment | **High-Yield:** The gold standard is **stratified randomization** with **complete baseline documentation**. This ensures: - Balanced distribution of known confounders - Ability to perform subgroup analyses - Transparency in reporting (CONSORT guidelines) ### Why Baseline Investigations Are Universal **Clinical Pearl:** Even in double-blind RCTs, baseline investigations are performed openly because they establish the reference point for measuring change. They are not blinded because they precede randomization. **Mnemonic: BASELINE** — **B**iomarkers, **A**ge/demographics, **S**everity (clinical), **E**ligibility confirmation, **L**aboratory values, **I**nclusion criteria, **N**eed for stratification, **E**quivalence verification. [cite:Park 26e Ch 10]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.